Volume 173, Issue 1 pp. 172-183
Epidemiology and Health Services Research

Statistical reporting in randomized controlled trials from the dermatology literature: a review of 44 dermatology journals

M. McClean

M. McClean

Department of Dermatology, Northwestern University Feinberg School of Medicine, Suite 1600, 676 N. St Clair St, Chicago, IL, 60611 U.S.A.

Search for more papers by this author
J.I. Silverberg

Corresponding Author

J.I. Silverberg

Department of Dermatology, Northwestern University Feinberg School of Medicine, Suite 1600, 676 N. St Clair St, Chicago, IL, 60611 U.S.A.

Department of Preventive Medicine and Medical Social Sciences, Northwestern University Feinberg School of Medicine, Suite 1600, 676 N. St Clair St, Chicago, IL, 60611 U.S.A.

Correspondence

Jonathan I. Silverberg.

E-mail:[email protected]

Search for more papers by this author
First published: 18 May 2015
Citations: 12
Funding sources No external funding.
Conflicts of interest None declared.

Summary

Background

The validity of randomized controlled trials (RCTs) is determined by several statistical factors.

Objectives

To determine the level of recent statistical reporting in RCTs from the dermatology literature.

Methods

We searched MEDLINE for all RCTs published between 1 May 2013 and 1 May 2014 in 44 dermatology journals.

Results

Two hundred and ten articles were screened, of which 181 RCTs from 27 journals were reviewed. Primary study outcomes were met in 122 (67·4%) studies. Sample size calculations and beta values were reported in 52 (28·7%) and 48 (26·5%) studies, respectively, and nonsignificant findings were supported in only 31 (17·1%). Alpha values were reported in 131 (72·4%) of studies with 45 (24·9%) having two-sided P-values, although adjustment for multiple statistical tests was performed in only 16 (9·9% of studies with ≥ two statistical tests performed). Sample size calculations were performed based on a single outcome in 44 (86·3%) and multiple outcomes in six (11·8%) studies. However, among studies that were powered for a single primary outcome, 20 (45·5%) made conclusions based on multiple primary outcomes. Twenty-one (41·2%) studies relied on secondary/unspecified outcomes. There were no differences for primary outcome being met (Chi-square, = 0·29), sample size calculations ( 0·55), beta values (= 0·89), alpha values (= 0·65), correction for multiple statistical testing (= 0·59), two-sided alpha (= 0·64), support of nonsignificant findings (Fisher's exact, = 0·23) based on the journal's impact factor.

Conclusions

Levels of statistical reporting are low in RCTs from the dermatology literature. Future work is needed to improve these levels of reporting.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.